mounjaro glp 1 Stroke: GLP-1s Like Ozempic, May Reduce Cardiovascular Risks Could GLP-1 Weight Loss Drugs
Description
e00712, Sep
Combined with the theory of GIP being an obesogenic hormone (53), these prior findings have highlighted the potential of GIP receptor antagonism, and today the development of GIP receptor antagonists has also emerged as an attractive therapeutic approach for addressing obesity and cardiovascular diseases (54, 55)
Lancet 394 , 121130 (2019)
Our Concerns About Pendulum's Marketing Our main issue with the way Pendulum is currently marketing this supplement relates to the suggestion that this supplement increases GLP-1 levels
